Advanced Prosthetic Foot Technology Manufacturer with Proprietary IP

This is a premium U.S.-based manufacturer specializing in advanced prosthetic foot technology, offering innovative lower-limb solutions for amputees. The company boasts 25 CMS-approved PDAC billing codes, ensuring high reimbursement potential and premium margins within the prosthetic foot segment. Strategically positioned in the rapidly expanding $1.6 billion diabetic foot loss market, the business offers strong price-to-value economics and some of the most natural-feeling prosthetic foot systems available. Products are engineered using aerospace-derived composite materials for lightweight strength, superior flexibility, and long-term durability. Key differentiators include proprietary manufacturing using aerospace-grade resins, efficient unit economics, scalable infrastructure, and independent testing to support users up to 500 lbs. The business operates with a fully turnkey model, including supply chain and brand presence, and offers pediatric and adult lines with adjustable heel tensioning. Customer acquisition is driven by B2B relationships with clinicians and direct marketing, with a new multi-channel campaign underway to accelerate distribution. The business presents a high barrier to entry for competitors, requiring over $10M and 5+ years to match product and PDAC approvals. This opportunity offers a fully operational and regulatory-compliant platform ready for national or international expansion, with marketing identified as the primary untapped growth lever.